<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Psychiatry: Allergy Topic Collection</title>
    <link>http://archpsyc.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Mon, 17 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:43:56 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpsyc.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpsyc.jamanetwork.com</webMaster>
    <item>
      <title>Transcranial Magnetic Stimulation of Left Temporoparietal Cortex and Medication-Resistant Auditory Hallucinations</title>
      <link>http://archpsyc.jamanetwork.com/article.aspx?articleID=207057</link>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <author>Hoffman RE, Hawkins KA, Gueorguieva R, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background&lt;/div&gt;Neuroimaging studies suggest that auditory hallucinations (AHs) of speech arise, at least in part, from activation of brain areas underlying speech perception. One-hertz repetitive transcranial magnetic stimulation (rTMS) produces sustained reductions in cortical activation. Recent results of 4-day administration of 1-Hz rTMS to left temporoparietal cortex were superior to those of sham stimulation in reducing AHs. We sought to determine if a more extended trial of rTMS could significantly reduce AHs that were resistant to antipsychotic medication.&lt;div class="boxTitle"&gt;Methods&lt;/div&gt;Twenty-four patients with schizophrenia or schizoaffective disorder and medication-resistant AHs were randomly allocated to receive rTMS or sham stimulation for 9 days at 90% of motor threshold. Patients receiving sham stimulation were subsequently offered an open-label trial of rTMS. Neuropsychological assessments were administered at baseline and during and following each arm of the trial.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Auditory hallucinations were robustly improved with rTMS relative to sham stimulation. Frequency and attentional salience were the 2 aspects of hallucinatory experience that showed greatest improvement. Duration of putative treatment effects ranged widely, with 52% of patients maintaining improvement for at least 15 weeks. Repetitive transcranial magnetic stimulation was well tolerated, without evidence of neuropsychological impairment.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;These data suggest that the mechanism of AHs involves activation of the left temporoparietal cortex. One-hertz rTMS deserves additional study as a possible treatment for this syndrome.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">60</prism:volume>
      <prism:number xmlns:prism="prism">1</prism:number>
      <prism:startingPage xmlns:prism="prism">49</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">56</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archpsyc.60.1.49</prism:doi>
      <guid>http://archpsyc.jamanetwork.com/article.aspx?articleID=207057</guid>
    </item>
  </channel>
</rss>